Drug Eluting Balloon Market Size, Share, Trend, Outlook, Future Analysis And Synthesis By 2026 Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe. Get FREE In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/2459 Market Dynamics Increasing prevalence of coronary artery diseases is a major factor driving drug eluting balloon market growth. According to American College of Cardiology, June 2017, around 17.92 million cardiovascular deaths were registered in 2015 worldwide. Moreover, key players in the market are focused on adopting acquisition strategies in order to gain access to innovative products and expand their product offerings in the potential markets. For instance, in April 2010, Medtronic acquired Invatec and affiliated companies. Invatec launched 4 new drug eluting balloons in Europe in 2009 including In.Pact Amphirion, In.Pact Admiral, In.Pact Pacific, and In.Pact Falcon. Medtronic is focused on enhancing its international presence by expanding treatment option for patients with cardiovascular disease. Increasing prevalence of coronary artery disease and diabetes is expected to propel growth of the drug eluting balloon market Drug eluting balloon is an angioplasty balloon, which plays a vital role in treatment of coronary artery disease. High prevalence of coronary artery disease is expected to propel demand for angioplasty and other treatments, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), around 3.8 million men and 4.4 million women die, annually from coronary heart disease worldwide. Moreover, the number of deaths from age 15 to 59 is around 1332 thousands and for above 60 years of age is around 5825 thousands. Report includes chapters which deeply display the following deliverable about industry : • Drug Eluting Balloon Market Research Objective and Assumption • Drug Eluting Balloon Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Drug Eluting Balloon Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Drug Eluting Balloon Market, By Regions • Drug Eluting Balloon Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Drug Eluting Balloon Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Drug Eluting Balloon Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Drug Eluting Balloon Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Increasing adoption of drug eluting balloon in North America is expected to bolster the market growth North America holds dominant position in the global drug eluting balloon market, owing to high prevalence of obesity, which further develops cardiovascular and coronary artery diseases. In October 2017, according to the National Center for Health Statistics (NCHS), estimated the prevalence of obesity in adults was around 39.8% and in youth 18.5% in the year 2015 -16 in the U.S. Increasing prevalence of cardiovascular diseases developed from tobacco and smoking in the region is also expected to boost the market growth. Key Players Major players operating in the global drug eluting balloon market include, Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik. Detailed Segmentation: Global Drug Eluting Balloon Market, By Product Type: • Coronary Drug Eluting Balloon • Peripheral Drug Eluting Balloon • Others Global Drug Eluting Balloon Market, By End User: • Hospitals • CATH Laboratories • Ambulatory Surgical Centers • Others Global Drug Eluting Balloon Market, By Geography: • North America • Europe • Asia Pacific • Latin America • Middle East • Africa Request For Customization of This Exclusive Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2459 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
The global drug eluting balloon market size was valued at US$ 420 million in 2017, and is expected to exhibit a CAGR of 8.1% over the forecast period (2018 – 2026).
© Copyright 2024 Paperzz
